Leadership Overview
RemeGen has 4 executives leading key functions including strategy, finance, and operations.
Driven by scientific advancement, RemeGen is dedicated to developing innovative biopharmaceutical solutions for autoimmune diseases and cancers, aiming to serve patients globally with its robust product pipeline and advanced technology.
Driven by scientific advancement, RemeGen is dedicated to developing innovative biopharmaceutical solutions for autoimmune diseases and cancers, aiming to serve patients globally with its robust product pipeline and advanced technology.
Leadership Roles at RemeGen
Jianmin Fang - Chief Executive Officer and CSO
Jianmin Fang, the Chief Executive Officer and CSO at RemeGen, directs the company's overarching strategy and scientific research initiatives. Overseeing the development of innovative drugs for autoimmune diseases and cancers, Fang ensures the progression of RemeGen's robust product pipeline. This leadership role involves guiding the scientific teams in their pursuit of novel therapies, including flagship products like Telitacicept and Disitamab Vedotin. Fang's strategic vision propels the company's mission to serve patients globally through advanced technology and strong scientific support. The Chief Executive Officer and CSO's focus remains on translating cutting-edge research into tangible patient benefits, solidifying RemeGen's position in the biopharmaceutical landscape. Jianmin Fang drives the scientific direction, ensuring alignment with market needs and therapeutic advancements.
Jian Lin - Executive Director & Chief Executive Officer
Jian Lin, the Executive Director & Chief Executive Officer at RemeGen, spearheads the company's strategic direction and operational execution. Lin's leadership ensures the effective deployment of resources towards developing innovative biopharmaceutical solutions for autoimmune diseases and cancers. This involves overseeing the commercialization strategies for key products such as Telitacicept and Disitamab Vedotin, and managing the expansion of the company's extensive research and development pipeline. The Executive Director & Chief Executive Officer's responsibilities encompass fostering global patient access to RemeGen's advanced therapies. Jian Lin drives the company's growth, focusing on market penetration and sustained innovation to address critical unmet medical needs. This executive's purview includes ensuring operational excellence across all business units.
Shaojing Tong - Chief Financial Officer
Shaojing Tong, the Chief Financial Officer at RemeGen, manages the company's financial operations and strategic fiscal planning. Tong oversees all aspects of financial reporting, budgeting, and investment strategies, ensuring the fiscal health of the organization as it develops innovative drugs for autoimmune diseases and cancers. This role is critical in supporting the robust product pipeline and the global market expansion of RemeGen's flagship products, Telitacicept and Disitamab Vedotin. The Chief Financial Officer's expertise guides resource allocation, enabling the company to leverage its advanced technology and scientific support effectively. Shaojing Tong ensures financial stability and optimizes capital deployment to drive RemeGen's mission of serving patients worldwide. This executive's oversight is fundamental to sustainable growth and operational efficiency.
Kaisheng Huang - Chief Operating Officer & Chief Quality Officer
Kaisheng Huang, the Chief Operating Officer & Chief Quality Officer at RemeGen, directs the company's operational efficiency and upholds stringent quality standards across all development and manufacturing processes. Huang oversees the complex supply chain and production of innovative biopharmaceutical products, including Telitacicept and Disitamab Vedotin, ensuring compliance with global regulatory requirements. This leadership position is vital for maintaining the integrity of RemeGen's robust product pipeline and facilitating the global delivery of its advanced therapies. The Chief Operating Officer & Chief Quality Officer's focus on operational excellence supports the company's mission to serve patients effectively. Kaisheng Huang drives the seamless execution of RemeGen's business objectives, ensuring product quality and operational scalability. This executive's role is central to maintaining the company's reputation for reliability and innovation.
Explore Leadership Teams in Manufacturing
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Company Leadership GA
ZP
AH
DL
Hemofarm is the leading pharmaceutical company in Serbia and in the region. Care for your health is the company's most important commitment. Hemofarm is a leader in the Serbian pharmaceutical market with a 17.3% share in financial terms. Holding a 79.1% share in the export of Serbian pharmaceutical products, the Vrac-based company is at the same time the leading Serbian exporter of medicinal products. Hemofarm produces over 4 billion tablets and capsules a year.
Company Leadership DS
DV
VA
TM
Jamjoom Pharma is one of the leading pharmaceutical companies in the Afrasia region focused on the Middle East, Africa, and CIS countries. Based in Jeddah, Saudi Arabia, Jamjoom Pharma manufactures and markets pharmaceutical products, over the counter (OTC) medicines, and health related consumer products. The company is owned by the Jamjoom Group.
Company Leadership NS
TH
AM
AH
Organon creates, manufactures and markets innovative prescription medicines that improve the health and quality of human life. Through a combination of innovation and business partnerships, Organon seeks to leverage each of its core therapeutic fields.
Company Leadership
MM
JS
MA
Frequently Asked Questions Regarding RemeGen Top Executives and Leadership Team
